טוען...
Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
BACKGROUND: Diagnosis of metastatic castrate resistant prostate cancer (mCRPC) with current biomarkers is difficult and often results in unnecessary invasive procedures as well as over-diagnosis and over-treatment. There are a number of prognostic biomarkers for CRPC, but there are no validated pred...
שמור ב:
| הוצא לאור ב: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448351/ https://ncbi.nlm.nih.gov/pubmed/32863768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01508-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|